Mounjaro can boost weight loss in people without diabetes
People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...
Here’s How Eli Lilly and Company (LLY) Contributed to Parnassus Core Equity Fund’s Performance
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...
EurekAlert!1d
Announcing Maxwell Biosciences as Tier 1 Sponsor of ARDD 2025
The University of Copenhagen is excited to announce Maxwell Biosciences as Tier 1 Sponsor of the 12th Aging Research & Drug ...
‘Miracle’ Alzheimer’s drug ‘triggers deadly brain bleeds in up to a third’, new study finds
AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...
ProQR Announces Year End 2024 Operating and Financial Results
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for ...
News-Medical.Net on MSN6d
Tirzepatide helps people without diabetes lose 13% body weight in real-world study
A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
EurekAlert!1d
Synthetic mRNA therapy: A new weapon against metastatic cancer
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
pharmaphorum1d
Digital health round-up: Lilly joins with Evidation to find digital measures of health
Eli Lilly has expanded a collaboration with data firm Evidation to analyse data from wearables and other devices to uncover novel digital measures of health. Lilly’s scientists and researchers ...